UnlockSAGE Therapeutics Files Mixed Shelf
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SAGE Therapeutics Inc (SAGE)
NASDAQ
Currency in USD
Disclaimer
7.50
-0.40(-5.06%)
Closed
After Hours
7.50-0.01(-0.13%)
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.45
8.00
52 wk Range
7.19
28.26
SAGE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SAGE Therapeutics Inc stock price live, this page displays NASDAQ SAGE stock exchange data. View the SAGE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SAGE Therapeutics Inc real time stock price chart below.
What Is the SAGE Therapeutics Inc Stock Price Today?
The SAGE Therapeutics Inc stock price today is 7.50.
What Is the Stock Symbol for SAGE Therapeutics Inc?
The stock ticker symbol for SAGE Therapeutics Inc is SAGE.
Is SAGE the Same as $SAGE?
$SAGE is a common way to refer to the SAGE Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does SAGE Therapeutics Inc Trade On?
SAGE Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is SAGE Therapeutics Inc a Good Stock to Buy?
Determining whether SAGE Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current SAGE Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SAGE quote. (ISIN: US78667J1088)
What Is the SAGE Therapeutics Inc Stock Price Today?
The SAGE Therapeutics Inc stock price today is 7.50.
What Is the Stock Symbol for SAGE Therapeutics Inc?
The stock ticker symbol for SAGE Therapeutics Inc is SAGE.
Is SAGE the Same as $SAGE?
$SAGE is a common way to refer to the SAGE Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does SAGE Therapeutics Inc Trade On?
SAGE Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is SAGE Therapeutics Inc a Good Stock to Buy?
Determining whether SAGE Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current SAGE Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SAGE quote. (ISIN: US78667J1088)
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.458.00
52 wk Range
7.1928.26
SAGE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
14.33
Upside
+91.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Sage Therapeutic receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sage Potash Shares to Resume Trading
- Investing.com
- SAGE Therapeutics Files Mixed Shelf
- Investing.com
- Sage Potash Shares to Resume Trading
- Investing.com
SAGE Therapeutics Inc Company Profile
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; and ZURZUVAE, a neuroactive steroid, a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, for the treatment of postpartum depression. Its product pipeline also comprises SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson’s diseases; and SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which is in Phase II clinical trial for the treatment of depression, Huntington’s disease, Parkinson’s diseases, Alzheimer’s disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. The company has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Compare SAGE to Peers and Sector
Metrics to compare | SAGE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSAGEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.0x | −2.2x | −0.6x | |
PEG Ratio | −0.04 | 0.00 | 0.00 | |
Price / Book | 0.7x | 2.5x | 2.6x | |
Price / LTM Sales | 4.8x | 10.5x | 3.1x | |
Upside (Analyst Target) | 41.6% | 550.4% | 55.0% | |
Fair Value Upside | Unlock | 36.8% | 6.8% | Unlock |
People Also Watch
FAQ
What Is the SAGE Therapeutics (SAGE) Stock Price Today?
The SAGE Therapeutics stock price today is 7.50
What Stock Exchange Does SAGE Therapeutics Trade On?
SAGE Therapeutics is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for SAGE Therapeutics?
The stock symbol for SAGE Therapeutics is "SAGE."
What Is the SAGE Therapeutics Market Cap?
As of today, SAGE Therapeutics market cap is 460.93M.
What is SAGE Therapeutics Earnings Per Share?
The SAGE Therapeutics EPS is -7.41.
What Is the Next SAGE Therapeutics Earnings Date?
SAGE Therapeutics will release its next earnings report on Nov 05, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.